mNEXSPIKE Dosage

Preparation for Administration

•

Verify that the label on the prefilled syringe states 2025-2026 Formula.

•

If prefilled syringes of MNEXSPIKE are frozen, thaw before use following the instructions below.

•

After thawing, do not refreeze.

•

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

•

MNEXSPIKE is a white to off-white suspension. It may contain white or translucent product-related particulates. Do not administer if vaccine is discolored or contains other particulate matter.

•

Do not shake.

•

With tip cap upright, remove tip cap by twisting counterclockwise until tip cap releases. Remove tip cap in a slow, steady motion. Avoid pulling tip cap while twisting.

•

Attach the needle by twisting in a clockwise direction until the needle fits securely on the syringe.

•

Discard after single use.

Administration

Administer MNEXSPIKE intramuscularly.

​2.3 Dosing and Schedule

​Administer MNEXSPIKE as a single 0.2 mL dose.

​For individuals previously vaccinated with any COVID-19 vaccine, administer the dose of MNEXSPIKE at least 3 months after the last dose of COVID-19 vaccine.